A world-first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly ‘super-bug’, Methicillin-resistant staphylococcus aureus (MRSA) Bacteremia, commonly known as Golden Staph.
Source: Second antibiotic no advantage for treating super-bug Golden Staph